CAR T-Cell Therapy Shown Safe, Effective in MCL With CNS Involvement

A small study suggests the use of anti-CD19 chimeric antigen receptor (CAR) T-cell therapy in patients with mantle cell lymphoma (MCL) with secondary central nervous system (CNS) involvement is safe and effective.

Related Keywords

United States ,United Kingdom ,British , ,Us Lymphoma Cart Consortium ,British Journal ,Cmcl ,Mantle Cell Lymphoma ,Cart Cell Therapy ,